Nature Communications (Jun 2021)

Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission

  • Xiao L. Chang,
  • Gabriela M. Webb,
  • Helen L. Wu,
  • Justin M. Greene,
  • Shaheed Abdulhaqq,
  • Katherine B. Bateman,
  • Jason S. Reed,
  • Cleiton Pessoa,
  • Whitney C. Weber,
  • Nicholas Maier,
  • Glen M. Chew,
  • Roxanne M. Gilbride,
  • Lina Gao,
  • Rebecca Agnor,
  • Travis Giobbi,
  • Jeffrey Torgerson,
  • Don Siess,
  • Nicole Burnett,
  • Miranda Fischer,
  • Oriene Shiel,
  • Cassandra Moats,
  • Bruce Patterson,
  • Kush Dhody,
  • Scott Kelly,
  • Nader Pourhassan,
  • Diogo M. Magnani,
  • Jeremy Smedley,
  • Benjamin N. Bimber,
  • Nancy L. Haigwood,
  • Scott G. Hansen,
  • Timothy R. Brown,
  • Lishomwa C. Ndhlovu,
  • Jonah B. Sacha

DOI
https://doi.org/10.1038/s41467-021-23697-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

CCR5 is a co-receptor for many transmitted HIV strains. Here, the authors show that biweekly injection of the CCR5-specific antibody Leronlimab protects rhesus macaques against infection following repeated intrarectal challenges of a CCR5-tropic SHIV.